AGREEMENT FOR AMENDMENT TO SERIES A AND SERIES B WARRANTSAgreement for Amendment to Series a and Series B Warrants • December 12th, 2017 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 12th, 2017 Company Industry JurisdictionTHIS AGREEMENT FOR AMENDMENT TO SERIES A AND SERIES B WARRANTS (this “Amendment Agreement”) is dated as of December 11, 2017, by and between Repros Therapeutics, Inc., a Delaware corporation (the “Company”) and the investor listed in the signature page attached hereto (the “Holder”).